SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-032828
Filing Date
2024-03-18
Accepted
2024-03-18 16:10:11
Documents
69
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tnya-20231231.htm   iXBRL 10-K 2421598
2 EX-10.10 tnya-ex10_10.htm EX-10.10 51511
3 EX-23.1 tnya-ex23_1.htm EX-23.1 3018
4 EX-31.1 tnya-ex31_1.htm EX-31.1 18208
5 EX-31.2 tnya-ex31_2.htm EX-31.2 18350
6 EX-32.1 tnya-ex32_1.htm EX-32.1 19468
7 EX-97 tnya-ex97.htm EX-97 48327
8 GRAPHIC img252036137_0.jpg GRAPHIC 127702
  Complete submission text file 0000950170-24-032828.txt   9318075

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tnya-20231231.xsd EX-101.SCH 1360676
73 EXTRACTED XBRL INSTANCE DOCUMENT tnya-20231231_htm.xml XML 1346073
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40656 | Film No.: 24759110
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)